Glycopyrrolate topical - Dermira

Drug Profile

Glycopyrrolate topical - Dermira

Alternative Names: DRM-04B; DRM04; DRM04 Topical Wipes; Glycopyrronium cloth; Glycopyrronium topical wipes; Glycopyrronium tosylate; Glycopyrronium tosylate hydrate; Glycopyrronium tosylate monohydrate; Qbrexza; Qbrexza™ Cloth

Latest Information Update: 03 Jul 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Stiefel Laboratories
  • Developer Dermira
  • Class Antiasthmatics; Antispasmodics; Antiulcers; Pyrrolidines; Quaternary ammonium compounds; Skin disorder therapies; Small molecules
  • Mechanism of Action Muscarinic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Registered Hyperhidrosis

Most Recent Events

  • 29 Jun 2018 Registered for Hyperhidrosis (In children, In adolescents, In adults) in USA - First global approval (Topical)
  • 16 Feb 2018 Additional efficacy and adverse events data from the phase III ARIDO trial in Hyperhidrosis presented at the 76th Annual Meeting of the American Academy of Dermatology (AAD-2018)
  • 16 Feb 2018 Pooled efficacy and adverse events data from the phase III trials ATMOS-1 and ATMOS-2 in Hyperhidrosis presented at the 76th Annual Meeting of the American Academy of Dermatology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top